Search research articles
Contact Us
Filters
Showing results (581-590 of 666) with videos related to
Page
of 67
Sort By:
JCO Precision Oncology
|
September 11, 2020
Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer
Simpa S Salami, Jeremy B Kaplan, Srinivas Nallandhighal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 13, 2020
Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials
William C Jackson, Holly E Hartman, Robert T Dess, et al.
Nature
|
December 10, 2025
Publisher Correction: CRISPR activation for SCN2A-related neurodevelopmental disorders
Serena Tamura, Andrew D Nelson, Perry W E Spratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials
Andrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.
European Urology
|
November 14, 2019
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials
Amar U Kishan, Fang-I Chu, Christopher R King, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 9, 2026
Correlation of Biochemical Recurrence with Adverse Late Toxic Events Following Prostate Radiotherapy (COBALT Study): An Individual Patient Data Meta-Analysis of 7 Randomized Trials
John Nikitas, Parsa Jamshidian, Alison C Tree, et al.
JCO Clinical Cancer Informatics
|
May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials
Mack Roach, Jingbin Zhang, Osama Mohamad, et al.
Nature
|
September 17, 2025
CRISPR activation for SCN2A-related neurodevelopmental disorders
Serena Tamura, Andrew D Nelson, Perry W E Spratt, et al.
Acta Neuropathologica Communications
|
July 28, 2018
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry
Hunter C Gits, Maia Anderson, Stefanie Stallard, et al.
Prostate Cancer and Prostatic Diseases
|
December 9, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer
Udit Singhal, Ralph Jiang, James A Proudfoot, et al.
Page
of 67
Search research articles
Search
Showing results (581-590 of 666) with videos related to
Sort By:
Page
of 67
JCO Precision Oncology
|
September 11, 2020
Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer
Simpa S Salami, Jeremy B Kaplan, Srinivas Nallandhighal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 13, 2020
Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials
William C Jackson, Holly E Hartman, Robert T Dess, et al.
Nature
|
December 10, 2025
Publisher Correction: CRISPR activation for SCN2A-related neurodevelopmental disorders
Serena Tamura, Andrew D Nelson, Perry W E Spratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials
Andrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.
European Urology
|
November 14, 2019
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials
Amar U Kishan, Fang-I Chu, Christopher R King, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 9, 2026
Correlation of Biochemical Recurrence with Adverse Late Toxic Events Following Prostate Radiotherapy (COBALT Study): An Individual Patient Data Meta-Analysis of 7 Randomized Trials
John Nikitas, Parsa Jamshidian, Alison C Tree, et al.
JCO Clinical Cancer Informatics
|
May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials
Mack Roach, Jingbin Zhang, Osama Mohamad, et al.
Nature
|
September 17, 2025
CRISPR activation for SCN2A-related neurodevelopmental disorders
Serena Tamura, Andrew D Nelson, Perry W E Spratt, et al.
Acta Neuropathologica Communications
|
July 28, 2018
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry
Hunter C Gits, Maia Anderson, Stefanie Stallard, et al.
Prostate Cancer and Prostatic Diseases
|
December 9, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer
Udit Singhal, Ralph Jiang, James A Proudfoot, et al.
Page
of 67